Document:

AGREEMENT OF SALE

AGREEMENT OF SALE

AGREEMENT dated as of January 30, 2003, between Alpharma AS, a corporation organized under the laws of Norway and registered with the Norwegian Register of Companies with organisation number 971 135 123 ("Seller")  and Nopal, a corporation organized under the laws of Norway and registered with the Norwegian Register of Companies with organisation number 917 811 873("Buyer").

WHEREAS, the Seller is engaged in the distribution and sale of vitamin products and bandages and surgical tape products from a facility in Vennesla, Norway.

WHEREAS, the parties agree that bandages and surgical tape products (the "Bandage and Tape Business") is not a part of this sale transaction.

WHEREAS, Seller wishes to sell to Buyer and Buyer wishes to purchase the assets, properties, and rights of the vitamin products listed on Schedule 1 except to the extent such rights relate to the sale of vitamins in Denmark, Portugal and Indonesia which shall remain vested in Seller (the "Vitamin Business") subject to the liabilities of the Vitamin Business.

NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements hereinafter set forth, Seller and Buyer hereby agree as follows:

1.SALE AND TRANSFER OF ASSETS, LIABILITIES AND CERTAIN RELATED MATTERS.

(a)Sale of Assets.  On the terms and subject to the conditions of this Agreement, on the Closing Date (as hereinafter defined) Seller shall sell, assign, convey, transfer and deliver to Buyer, and Buyer shall purchase from Seller, the following assets, properties, and rights and liabilities related to the Vitamin Business:

	Inventory of products and packaging material listed on Schedule 1, including raw materials and work in process at the Lier plant and purchase commitments relating to the products and packaging material (the "Inventory")
	All existing contracts and agreements relating to the Vitamin Business including distributor, supplier, and customer agreements
	Customer lists
	Trade marks and other intellectual property rights owned by Seller or affiliated companies listed in  Schedule 2 except for the trademark "Vitapan" which shall be licensed to Buyer for use in the Vitamin Business on a 10 year, royalty-free basis with the right to renewal on terms to be agreed.
	Specifications and formulas for the products listed on Schedule 1

All such assets, properties, rights, and business being acquired by Buyer are collectively referred to herein as the "Purchased Assets".  It is understood and agreed that Buyer is not purchasing any real property, plant or equipment, accounts receivable, accounts payable or the trademark "Norgesplaster" and is not assuming any rights or obligations with respect to employees of Seller.

(b)Liabilities of Seller.  Buyer agrees to assume all liabilities existing on the date of the Closing related to the Vitamin Business and to continue to perform the following obligations of Seller related to the Vitamin Business:  

	All existing contracts and agreements relating to the  Vitamin Business including distributor, supplier, and customer agreements

(c)Purchase Price.  Upon the terms and subject to the conditions set forth in this Agreement, Buyer shall pay to Seller at the Closing, a cash purchase price for the Purchased Assets in immediately available funds of NOK 23 million plus the value of the Inventory as existing on the Closing Date; the value of which shall be computed in accordance with Schedule 3 (the "Purchase Price").

(d)Assignment of Contracts.  Seller shall use all reasonable diligence to obtain any third party consents necessary to effectuate the transfer of the contracts of Seller being assumed by Buyer hereunder.  If such consent is not obtained, or if an attempted assignment thereof would be ineffective or would adversely affect the rights of Seller thereunder so that Buyer would not, in fact, receive all such rights, Seller will cooperate with Buyer in any arrangement designed to provide for the benefits under any such claims, contracts, agreements, licenses, commitments, sales orders or purchase orders, and including, without limitation, enforcement for the benefit of Buyer of any right arising out of the breach or cancellation by a third party or otherwise.  In the event any individual contract or agreement relates to both the  Vitamin Business and the Bandage and Tape Business or other businesses of Seller said contract shall not be assigned to Buyer but, in lieu thereof, Seller shall take all reasonable action to provide Buyer with the benefit of such contract or agreement to the extent that it relates to the Vitamin Business and Buyer shall perform all obligations thereunder relating to the  Vitamin Business. 

(e)Inventory Adjustment

	The Seller shall within 15 days after the Closing Date procure that a statement of the Inventory as existing on the Closing Date (the "Inventory Statement"), which shall be prepared in accordance with the procedures and valuation rules set forth in Schedule 3 and, to the extent consistent with Schedule 3, applicable Norwegian accounting principles applied in the same manner as has been historically used by Seller
	As soon as the Inventory Statement shall have been prepared, the Seller shall send a draft copy thereof to the Buyer.
	Unless the Buyer shall within 15days after receipt of the Inventory Statement give a notice (an "Objection Notice") to the Seller that it objects to the Inventory Statement  (identifying the reason for any objection and the amount(s) or item(s) in the Inventory Statement which is/are in dispute), the Buyer shall be deemed to have irrevocably approved and agreed to the Inventory Statement in the form of the draft provided by the Seller.
	If, within the period referred to in paragraph (iii), the Buyer shall give an Objection Notice, then the Seller and the Buyer shall use their reasonable endeavours to reach agreement upon adjustments to the draft Inventory Statement.
	In the event that the Seller and the Buyer fail to reach agreement within 30 days following delivery of the Objection Notice, each of the Seller or the Buyer shall be entitled to refer the matter(s) in dispute to PricewaterhouseCoopers. Such independent firm of state authorised auditors shall determine the matter(s) in dispute and their decision shall be final and binding in the absence of manifest error. The independent firm of state authorised auditors may instruct valuers, lawyers and other professional advisers to the extent that they consider necessary to assist them in reaching their determination. The costs of the independent firm of state authorised auditors (including the fees of any professional advisers appointed by them as aforesaid) shall be borne by the Seller and the Buyer equally.
	If within the period referred to in paragraph (iii) the Buyer shall not have  given an Objection Notice or, if such notice is given and the Seller and the Buyer shall subsequently agree the draft Inventory Statement or the matters in dispute are referred to an independent firm of state authorised auditors under Clause 1 (f) (v), the draft Inventory Statement as adjusted (where applicable) so as to be in accordance with the agreement of the Seller and the Buyer or the determination of the independent state authorised auditors, shall be the Inventory Statement for the purposes of this Agreement and shall be final and binding upon the parties.

(vii)  When the Inventory Statement has become binding, the Purchase Price shall forthwith be increased by the amount of Inventory reflected on  the Inventory Statement. Seller shall send an invoice to Buyer for the amount given in the binding Inventory Statement.

	The increase in the Purchase Price reflected on the Inventory Statement shall be paid by the Buyer to the Seller within 45 days after the  Inventory Statement has become binding. Late payment will be charged  with interest thereon calculated at NIBOR plus 1.5 per cent per annum.

(g) Allocation of Purchase Price.  For tax and accounting purposes the Purchase Price must be allocated on the transferred assets and liabilities, including goodwill calculated as the eventual difference between net identifiable assets and the Purchase Price as further set out in Schedule 4. The parties shall, in the period up to execution of the Closing Accounts Statement subject to the provisions above, and for 15 days following such date, cooperate in order to establish, and to document in writing, the correct allocation of the Purchase Price compared to the Closing Accounts Statement. Such written documentation shall be the basis for the parties' respective accounting and tax returns.

2.CLOSING.

The Closing of the transactions provided for hereunder shall take place at the offices of Wiersholm, Mellbye & Bech, Ruselokkveien 26  0251 Oslo, Norway at 10:00 o'clock a.m. Oslo time on January 30, 2003, or on such other date, (the "Closing Date") or at such other place, as Seller and Buyer may agree (the "Closing").

3.REPRESENTATIONS AND WARRANTIES BY SELLER.

Seller represents, warrants, and covenants that, except to the extent disclosed in the Disclosure Bundle delivered by Seller to Buyer concurrently herewith: 

(a)Organization of Seller.  Seller is a corporation duly organized and validly existing under the laws of Norway and has all power and authority to own and hold properties of the  Vitamin Business, to conduct the  Vitamin Business as such business is now being conducted, to enter into and perform its obligations under this Agreement.

(b)Ability to Carry Out Agreement.  Seller is not a party to, subject to, or bound by any agreement or instrument or any statute, regulation, pending litigation, judgment, order writ, injunction, or decree of any court or governmental body which could at the date of the Closing prevent the performance of any of its obligations under this Agreement or adversely affect the use by Buyer of the Purchased Assets or Buyer's ability to engage in the  Vitamin Business as it is presently conducted.

(c)Authorization and Approval of Agreement.  Seller has full corporate power and authority to enter into this Agreement and to carry out the transactions contemplated hereby.  The execution, delivery and performance by Seller of this Agreement has been approved by Seller's Board of Directors and requires no further corporate action for valid authorization.  This Agreement upon its execution and delivery by Seller (assuming due authorization, execution, and delivery by Buyer) will constitute the legal, valid and binding obligation of Seller, enforceable in accordance with its terms, subject to the effect of applicable bankruptcy, insolvency, reorganization, moratorium and other similar laws affecting creditors rights generally.

(d)Financial.  Attached hereto as Schedule 5 is a true, correct and complete copy of the statement of income for the 12 months ended December 31, 2001 of the Vitamin Business(the "2001 Income Statement"). The 2001 Income Statement has been prepared in accordance with accounting principles generally accepted in Norway and present fairly in all material respects the on a pro forma basis revenues and direct operating expenses for the Vitamin Business for the period then ended.  Since December 31, 2001, the Vitamin Business has been operated only in the ordinary and normal course of business and there has not been (a) any material adverse change in the financial condition or in the operations of the  Vitamin Business from that shown on the 2001 Income Statement ; (2) any damage, destruction, or loss materially and adversely affecting the properties of the  Vitamin Business; or (3) any other event or condition of any character pertaining to and materially and adversely affecting or threatening to affect the Purchased Assets or the  Vitamin Business.

(e)     Title of Assets.  Other than liens for current taxes not yet due and payable, Seller has good and marketable title to all of the Purchased Assets, free and clear of all mortgages, liens, or other encumbrances.  All of the Purchased Assets are in the possession and control of Seller, and, as of the Closing Date, no third party will have any right pertaining to the Purchased Assets. The Sellers right to the Purchased Assets are not subject to the payment of any royalty, contingent payment or other consideration.

(f)     Insurance. All relevant insurance policies relevant for the Vitamin Business are in full force and effect and provide adequate insurance coverage for the assets and operations of the Vitamin Business.  The Seller is not in default with respect to any provision contained in any such policy, nor has it failed to give notice or pursue any claim under any insurance policy in due and timely fashion.  For avoidance of doubt Seller's policies of insurance shall not cover the Vitamin Business on or after the Closing Date.  

(g)Contracts and Commitments.  Each contract or obligation of Seller as pertains to the  Vitamin Business is in full force and effect, constitutes the valid legal and binding obligation of Seller and, to Seller's knowledge,  is the valid, legal and binding obligation of the other party(ies) thereto and Seller is not in any default, nor is there any claim of default, under any contracts or obligations of Seller which would adversely affect the  Vitamin Business as a whole.

(h)No Breach of Statute or Contract.  Neither the execution and delivery of this Agreement nor compliance with the terms and provisions of this Agreement on the part of Seller will breach any statute or regulation of any governmental authority, domestic or foreign, or will at the Closing Date conflict with or result in a breach of any of the terms, conditions, or provisions of any agreement or instrument to which Seller is a party or by which it is or may be bound, or constitute a default thereunder, or result in the creation or imposition of any lien, charge, or encumbrance of any nature whatsoever upon, or give to others any interest or rights in the properties or Purchased Assets.

(i)No Litigation or Adverse Events.  There is no, and nor does the Seller know of any basis or grounds for any, claim, suit, action, or legal, administrative, arbitration, or other proceeding or governmental investigation, or any change in the zoning or building ordinances affecting the Vitamin Business, pending or threatened, which could reasonably materially adversely affect the financial condition of the  Vitamin Business as a whole.  

(j)Trademarks. Schedule 2 contains a complete and accurate list of all Trademarks in use by Seller in the  Vitamin Business. The Trademarks are duly registered in the countries listed on Schedule 2 for the products listed on Schedule 1. The Seller is the sole legal owner of such Trademarks. The registered Trademarks are valid, subsisting and not subject to any opposition or application for cancellation or amendment. All application, renewal and other official statutory and regulatory fees in respect of the Trademarks have been duly paid. No claim has been received by the Seller from any third party based on allegation of infringement of the Trademarks. To the best of Seller's knowledge, the Trademarks are not violating or infringing the rights of any third party, and no third party is violating or infringing upon the Trademarks.

No act has been done or omitted to be done and no event has occurred or is likely to occur which may render any registration of the Trademarks subject to revocation, compulsory licence, cancellation or amendment. To the best of Seller's knowledge, there are no agreements or arrangements in force which restrict in any manner the disclosure or use or assignment by Seller of any Trademark owned by the Seller.

(k)No employees. No employees of Seller will, as a result of the Agreement, be entitled to demand employment by the Buyer pursuant to the Norwegian Labour Protection Act, nor demand any compensation in this respect. Seller shall hold Buyer harmless of any such claims. 

(l)Compliance with Law.  The  Vitamin Business is not, and on the Closing Date will not be, in violation of any law or regulation, local, state, provincial or federal, pertaining to the operation or conduct of its business which violation would be materially adverse to the  Vitamin Business as a whole. 

(m)Governmental Permits. The Vitamin Business has all governmental or other public licenses and permits necessary to conduct its business, and such licenses and permits are in full force and effect.  For avoidance of doubt, while Seller will take any reasonable action to transfer such licenses and permits as relate solely to the Vitamin Business to Buyer, Seller makes no representation that such licenses or permits are transferable to Buyer under applicable law. 

(n)No Brokers or Finders.  No individual, firm, corporation or other person has, or as a result of any of the transactions contemplated hereby will have, as a result of any commitment of Seller with respect to such individual firm, corporation or other person any right, interest or valid claim against or upon Buyer for any commission, fee or other compensation as a broker or finder or for acting in any similar capacity.

4.REPRESENTATIONS AND WARRANTIES BY BUYER.

Buyer represents, warrants and covenants that

(a)Organization.  Buyer is a corporation duly organized and validly existing under the laws of Norway and has all corporate power and authority to own its properties, carry on its business as and where such business is now conducted and to enter into and perform its obligations under this Agreement.

(b)Authorization and Approval of Agreement.  Buyer has full corporate power and authority to enter into this Agreement and to carry out the transactions contemplated hereby.  The execution, delivery and performance of this Agreement by Buyer has been duly authorized by Buyer's Board of Directors and requires no further corporate action for valid authorization.  The Agreement upon its execution and delivery by Buyer (assuming due authorization, execution and delivery by Seller) will constitute the legal, valid and binding obligation of Buyer.

(c)Ability to Carry Out Agreement.  Buyer is not a party to, subject to or bound by any agreement or instrument or any statute, regulation, judgment, order, writ, injunction or decree of any court or governmental body which could at the date of the Closing prevent the performance of its obligations under this Agreement.

(d)No Breach of Statute or Contract.  Neither the execution and delivery of this Agreement nor compliance with the terms and provisions of this Agreement by the Buyer will breach any statute or regulation of any governmental authority, domestic or foreign or will at the Closing Date conflict with or result in a breach of any of the terms, conditions or provisions of any agreement or instrument to which Buyer is a party or by which it is or may be bound or constitute a default thereunder.

(e)No Brokers or Finders.  No individual, firm, corporation or other person has, or as a result of any of the transactions contemplated hereby will have, as a result of any commitment of Buyer with respect to such individual, firm, corporation or other person any right, interest, or valid claim against or upon Seller for any commission, fee or other compensation as broker or finder or for acting in any similar capacity.

5.CONDUCT OF THE BUSINESS OF THE  VITAMIN BUSINESS PENDING THE CLOSING DATE.

(a)Full Access.  Buyer and its authorized representatives shall have full access during normal business hours to all properties, books, records, tax returns, contracts and documents of Seller, as pertains to the  Vitamin Business and Seller shall furnish or cause to be furnished to Buyer and its authorized representatives all information in respect of the affairs of the  Vitamin Business as Buyer may reasonably request.  Any information disclosed by Buyer hereunder shall be kept confidential by Buyer and shall not be disclosed or used by Buyer (other than in connection with this Agreement) unless the Closing occurs.

(b)Carry on in Regular Course.  Seller represents, warrants and agrees that pending the Closing Date (subject to written consent by Buyer to the contrary which consent shall not be unreasonably withheld):

(i)Seller will carry on the  Vitamin Business diligently and substantially in the same manner as heretofore and shall not make or institute any unusual or novel methods of sale, lease, management, accounting, or operation. 

(ii)Seller will not bid upon or enter into any contract or commitment or engage in any transaction not in the usual and ordinary course of the  Vitamin Business and consistent with its past practices.

(iii)Seller will not sell, lease, transfer or otherwise dispose of its rights with respect to any of the Purchased Assets.

6.CONDITIONS PRECEDENT TO BUYER'S OBLIGATIONS.

The obligation of Buyer to consummate the transactions to be entered into at the Closing is subject only to each of the following:

(a)No Material Adverse Change.  No event shall have occurred, prior to the Closing, which materially and adversely affects the value of the assets, properties or business of the  Vitamin Business, unless such event is covered by insurance.

(b)Representations and Warranties and Compliance with Agreement.  The representations and warranties of Seller made hereunder are, at and as of the Closing, true in all material respects with the same effect as though such representations and warranties had been made or given on and as of the Closing, except for changes contemplated or permitted by or under this Agreement.

(c)Proceedings and Instruments Satisfactory.  All proceedings, corporate or other to be taken in connection with the transactions contemplated by this Agreement and all documents required in connection therewith or incident thereto, shall be satisfactory in form and substance to Buyer's counsel; and Seller shall have made available to Buyer for examination the originals or true and correct copies of all documents relating to the business and affairs of Seller which Buyer may reasonably request.

(d)     Delivery of Documents.  Buyer shall receive the deeds of transfer as referred to in Clause 1 (d) effectively transferring title to the Purchased Assets and such other title transfer documents as agreed between the Parties.

(e)     Distribution Agreement.  Buyer and Seller shall concurrently with the Closing execute the Distribution Agreement referred to in Section 9 (f) (ii) hereof.

(f)Waiver of Conditions by Buyer.  Buyer may, in its sole discretion, waive any one or more of the conditions precedent set forth in (a) through (e) above for the purpose of proceeding with the Closing.  Such waiver shall not have any effect on Seller's responsibilities and liabilities under the representations, warranties and agreements made hereunder.

7.CONDITIONS PRECEDENT TO SELLER'S OBLIGATIONS.

The obligation of Seller to consummate transactions to be entered into at the Closing is subject only to each of the following:

(a)Representations and Warranties and Compliance with Agreement.  The representations and warranties of Buyer made hereunder are, at and as of the Closing Date, true in all respects with the same effect as though such representations and warranties had been made or given on or as of the Closing Date, except for changes permitted by or under this Agreement.  

(b)Proceedings and Instruments Satisfactory.  All proceeding, corporate or other, to be taken in connection with the transactions contemplated by this Agreement and all instruments and documents required in connection therewith or incident thereto shall be satisfactory in form and substance to Seller's counsel.

(c)Delivery of Documents.  Seller shall have received all the documents according to this Agreement reasonably requested by its counsel.

(d)     Purchase Price.  Seller shall have received the Purchase Price in immediately available funds.

(e)     Bank Consent.  Seller shall have received all consents or waivers necessary to complete this transaction under its US $ 900 million Bank Credit Agreement dated October 5. 2001.

(f)     Distribution Agreement.  Buyer and Seller shall concurrently with the Closing execute the Distribution Agreement referred to in Section 9m (f) (ii) hereof.

(g)Waiver of Conditions by Seller.  Seller may, in its sole discretion, waive any one or more of the conditions precedent set forth in (a) through (f) above for the purpose of proceeding with the Closing.  Such waiver shall not have any effect on Buyer's responsibilities and liabilities under the representations, warranties and agreements made hereunder.

8.SURVIVAL OF REPRESENTATIONS AND WARRANTIES, ETC.

All representations, warranties and agreements made by the parties each to the other in this Agreement or pursuant hereto shall survive the Closing and any investigation made at any time with respect thereto for a period of twenty-four(24) months after the Closing. Seller's aggregate liability with respect to the breach of all representations, warranties and agreements contained herein is limited to the Purchase Price; provided that Buyer shall have no claim against Seller with respect to such representations, warranties or agreements unless and until (and only to the extent) the aggregate value of all such claims exceeds NOK 2 million.

9.CERTAIN AGREEMENTS OF SELLER AND BUYER.

(a)Records.  Seller shall deliver to buyer on the Closing Date or such other date as mutually agreed upon all of the contracts and written evidence of all of the commitments of Seller to be assumed by Buyer and all books of account records, and correspondence relating to the  Vitamin Business (except those pertaining solely to the internal corporate affairs of Seller).  Any books and records related to both the  Vitamin Business and the Bandage and Tape Business shall be retained by the Seller but shall be subject to the inspection and copying by Buyer at the  Seller's premises.  The books and records relating to the business of Seller retained by Seller and the books and records transferred to Buyer shall thereafter be available for inspection by the other party at any time during regular business hours for a period of five (5) years and such other party may make such excepts therefrom for valid and reasonable continuing business purposes at its own expense.

(b)Further Assurances.  From time to time after the Closing each party, at the request of the other without further consideration, agrees to execute and deliver at its expense such other instruments of transfer or assumption and take such other action as reasonably may be requested so as to more effectively transfer and vest in Buyer and to put Buyer in possession of any of the Purchased Assets.

(d)Insurance. Effective as of the Closing Date, the Buyer shall procure that all insurance have been obtained as required by law or customary used for the  Vitamin Business.  The Seller shall procure that all insurance in existence at the date hereof shall be maintained up to and including the Closing Date

(e)     Use of Alpharma Name.  Buyer is authorized to utilize the packaging which is a part of the Inventory on the Closing Date and Seller hereby grants to Buyer a royalty-free license (without the right of assignment or sublicense) to use the name "Alpharma" and any other designation which indicates that it is Seller's product as may be set forth on said existing packaging ; provided that (i) Buyer utilizes such packaging as soon as reasonably possible and in any event no later than two years after the Closing and (ii) Buyer takes all reasonable action to indicate to its customers that the products contained in such packaging are the sole responsibility of Buyer.  Buyer hereby agrees to indemnify and hold Seller harmless from and against any claims, liability, costs or damages in connection with or caused by reason of products sold after the Closing Date in packaging covered by this clause. 

(f)     Distributorship Agreements.  

	 The parties agree that the Distributorship Agreement, dated January 1, 1996, under which Buyer distributes vitamin products for Seller shall be terminated on the Closing Date.  Upon such termination it is agreed (i) that Buyer shall receive no further marketing allowances from Seller for any period prior to or after the Closing and (ii) Seller shall credit Buyer for certain short-shelf life inventory purchased under the Distributorship Agreement immediately prior to the Closing in accordance with the terms of paragraph 7 of Schedule 3  and (iii)  other than as set forth in (ii) above, Buyer shall pay all outstanding invoices for products delivered to it prior to the Closing Date within 30 days after the Closing Date and (iv) except to the extent stated in this clause (f), there shall be no further payments whatsoever under the Distributorship Agreement and each party waives and release all rights, liabilities and obligations against the other party under said Distributorship Agreement.
	On the Closing Date Buyer and Seller will enter into the Distribution Agreements in a form mutually agreeable to Buyer and Seller under  which (a) Buyer shall sell Seller's bandage and tape product to grocery store customers and (b) Seller shall sell the products of the Vitamin Business to pharmacy customers. Buyer and Seller agree to enter into good faith negotiations to reach agreement on the substance and form of a Distribution Agreement prior to the date of the Closing.

(g)Supply and Packaging  of Products.  On and after the Closing Seller shall continue to manufacture and package  certain products on the terms and conditions set forth in the Supply and Packaging Agreement attached hereto as Schedule 6.

(h)  Vendor and Customer Payments.  To the extent Buyer may, after the Closing Date receive payment of a customer or other account receivable related to the Vitamin Business outstanding on the Closing Date; it shall immediately transfer to Seller, for its own account, physical possession of the check or other incidence of payment.  If Buyer shall inadvertently allow the funds with respect to an account receivable described by the last sentence to be deposited in its account, it shall immediately transfer said funds to Seller.  If Buyer receives a payment from an entity owing money to both Seller and Buyer, it shall be deemed to be in payment of the then oldest outstanding account receivable.  If Seller receives a vendor or other invoice for services performed or goods delivered with respect to the Vitamin Business on or after the Closing Date, it shall immediately forward said invoice to Buyer who shall pay it in accordance with its terms.  If Seller shall inadvertently pay an invoice described by the last sentence, it shall provide Buyer with reasonable evidence of such payment and Buyer shall immediately reimburse Seller for such payment. 

10.ENTIRE AGREEMENT AND AMENDMENTS.

This Agreement, including the Schedules referred to herein which are a part hereof contains the entire understanding of the parties hereto with respect to the subject matter contained herein; supersedes and cancels all prior agreement in principle understandings or other agreement among any or all of the parties hereto or on behalf of any or all of them with respect to such subject matter; and may be amended only by a written instrument executed by Seller and Buyer or their respective successors or assigns.  There are no representations, promises, warranties, covenants, undertakings or understandings other than those expressly set forth herein.  This section and paragraph headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

	OFFICIAL VERSION AND COUNTERPARTS.

The version of this Agreement written in the English language shall be the only authentic version of this Agreement regardless of whether a translation is made in any other language.  This Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

	ANNOUNCEMENTS

The parties shall jointly agree the timing and form of announcements necessary or customary in relation to this Agreement.

13.COSTS 

Each party shall bear their own costs and expenses in relation to this Agreement. The Buyer shall pay all costs related to the transfer of the Purchased Assets (including real estate and intellectual property related transfer costs).

14.PARTIES IN INTEREST.

This Agreement shall inure to the benefit of and be binding upon Seller and Buyer and their respective affiliates, successors and assigns, but may not be assigned or otherwise transferred by operation of law or otherwise without the prior written consent of all the parties hereto and except as specified herein shall not create any rights on the part of any other person.  Any such assignment or transfer without such consent shall be void.

15.TERMINATION.

Either Buyer or Seller (without liability to the other) by written notice to the other, may, prior to the Closing, forthwith terminate this Agreement in the event (i) any representation or warranty made herein by the other party shall be untrue in any material respect, (ii) any of the conditions precedent to the performance of the obligations of the party given such notice shall not have been fulfilled as of the date specified herein for the Closing and shall not have been waived by such party, (iii) of a material default by the other party in observance or in the due and timely performance of any of the covenants and agreements herein contained that cannot be cured on or prior to the Closing, or (iv) Buyer and Seller shall mutually agree in writing to such termination.

16.NOTICES.

All notices, requests, demands and other communications shall be deemed to have been duly given if delivered or mailed, certified or registered mail with postage prepaid, if to Seller to:

Thor Kristiansen

Alpharma AS

Harbitzalleen 3

P.O. Box 158, Skoyen

N-0212 Oslo, Norway

with a copy to:     Marie N. Amerasinghe, Esq.

Vice President, Commercial Legal Affairs

Alpharma Inc.

One Executive Drive

Fort Lee, New Jersey 07024

or to such other person and place as the Seller shall furnish to Buyer in writing; and if to Buyer to:

Tor Harung

President

Nopal AS

Billingstadsletta 25

P.O. Box 135

N-1376 Billingstad, Norway

or to such other person and place as Buyer shall furnish to Seller in writing.

17.LAW GOVERNING.

This Agreement shall be governed by and interpreted in accordance with the laws of Norway. Any dispute arising out of this contract, or other contracts resulting from it, shall be finally settled by Arbitration pursuant to the Rules of Arbitration and Dispute Resolution Institute of the Oslo Chamber of Commerce in force at any time. 

18.WAIVERS.

Any party to this Agreement may, at its option, waive in writing any and all of the conditions herein contained to which its obligations hereunder are subject.  The failure on the part of any party to exercise any right, option or power arising out of or resulting from a breach or default by any other party of any term, provision or covenant of this Agreement shall not constitute a waiver of any such right, option or power as to any subsequent breach or default.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed.

ALPHARMA AS

 

By: _/s/ Thor Kristiansen___

Name:  Thor Kristiansen

Title:     Gen. Mngr.

NOPAL AS

 

By: _/s/ Tor Harung__________

Name: Tor Harung

Title:    President

 

Schedule 1

 

Vitamin Products

 

	
VITAMINERAL TAB 100 NO        

	
VITAMINERAL TAB 250 NO        

	
VITAPAN TRANPERLER 1000ENP    

	
VITAPAN TRANPERLER 150 APOTEK 

	
VITAPLEX ABCDE+8 MIN 8X80ENP  

	
VITAPLEX BARNEVITAMIN 8X80ENP 

	
VITAPLEX B-VITAMIN 8X80ENP    

	
VITAPLEX C-VITAMIN 8X80ENP    

	
VITAPLEX FRISKHALS 10X20ENP   

	
VITAPLEX HVITLØK 8X80ENP      

	
VITAPLEX KOSTTILSKUDD ENP     

	
VITAPLEX MAGNESIUM 100 APOTEK 

	
VITAPLEX TAB 1000             

	
VITAPLEX TAB 1000ENP          

	
VITAPLEX TAB 8X80ENP          

	
VITAPLEX VITAMINERAL 100 NO   

	
NORVITON 90 TAB 10 PAK

 

Schedule 2

 

Vitamin trademarks

 

 

	
Schedule of All Trademarks
	
	
	
	

	
	
	
	
	
	

	
	
	
	
	
	

	
Trademark
	
Country
	
Status
	
Owner
	
Registration No
	
Classes

	
VITAMINERAL
	
Norway
	
Registered
	
Dumex-Alpharma A/S
	
133723
	
5

	
VITAMINERAL
	
Thailand
	
Registered
	
Alpharma ApS
	
Kor130636
	
5

	
	
	
	
	
	

	
	
	
	
	
	

	
VITAPLEX
	
Denmark
	
Registered
	
Dumex-Alpharma A/S
	
00988/1954
	
5

	
VITAPLEX
	
Finland
	
Registered
	
Alpharma AS
	
22913
	
5

	
VITAPLEX
	
Iceland
	
Registered
	
Apothekernes Laboratorium AS
	
120/1960
	
5

	
VITAPLEX
	
Italy
	
Registered
	
Alpharma AS
	
376250
	
1, 5

	
VITAPLEX
	
Norway
	
Registered
	
Apothekernes Laboratorium AS
	
37926
	
5

	
VITAPLEX
	
Thailand
	
Registered
	
Dumex-Alpharma A/S
	
kor94113
	
5

	
	
	
	
	
	

	
NORVITON
	
Norway
	
Registered
	
Apothekernes Laboratorium AS
	
70768
	
5

	
	
	
	
	
	

 

Schedule 3

Vitamin Inventory Value

The value of the vitamin inventory shall be calculated according to the following principles:

	Finished Products with less than 6 months remaining shelf life shall be scrapped by seller.
	Finished Products with more than 6 months but less than 12 months remaining shelf life will be sold with 50% discount from the 2002 Alpharma selling price
	Finished Products with more than 12 months remaining shelf life will be sold with 33% discount from the 2002 Alpharma selling price for products to the grocery sector. 
	Products purchased from 3rd party supplier in finished form will be sold at purchase price
	Bulk Products will be sold at prices given in the table below. Packaging prices also outlined in same table
	Nopal is not obliged to buy inventory representing more than the 2003 budget annual sales volume
	Nopal shall be credited for inventory at their warehouse at Elverum  as follows:

	with less than 6 months remaining shelf life 100% credit
	inventory with more than 6 months but less than 12 months remaining shelf life 50% credit
	products with more than 12 months remaining shelf life 33% credit

	Inventory of raw materials and packaging materials shall, when applicable, be sold at Alpharma book inventory value

	
	
Bulk
	
Packaging

	
	
NOK/unit
	
NOK/unit

	
VITAMINERAL TAB 100 NO                     *
	
14,02
	

	
VITAMINERAL TAB 250 NO                     *
	
28,16
	

	
VITAPLEX ABCDE+8 MIN 8X80ENP  
	
55,10
	
40,00

	
VITAPLEX B-VITAMIN 8X80ENP    
	
36,90
	
50,00

	
VITAPLEX C-VITAMIN 8X80ENP    
	
48,80
	
40,00

	
VITAPLEX FRISKHALS 10X20ENP          *
	
61,40
	

	
VITAPLEX HVITLØK 8X80ENP      
	
68,40
	
30,00

	
VITAPLEX KOSTTILSKUDD ENP     
	
110,50
	

	
VITAPLEX TAB 1000             
	
50,00
	
52,50

	
VITAPLEX TAB 8X80ENP          
	
50,00
	
40,00

	
VITAPLEX VITAMINERAL 100 NO           *
	
14,02
	

	
NORVITON 90 TAB 10 PAK
	
16,10
	
6,00

* Products bought in finished form from 3rd  part supplier

 

 

Schedule 4

 

Allocation of Purchase Price

The total purchase price for the business, NOK 23.0 mill will be allocated as follows:

NOK 9.0 mill for trademarks

NOK 14.0 for goodwill

 

Schedule 5

 

2001 Statement of Income for the Vitamin business

	
Norgesplaster Vitamin Business
	
	

	
YEAR
	
	
	
2001

	
INCOME STATEMENT
	

	
In thousands
	
	

	
	
	

	
Gross sales
	
	
18 880

	
Sales reductions
	
	

	
Net sales (a)
	
	
18 880

	
Other operating revenue
	

	
Secondary income
	
	

	
Other revenue (b)
	
	
0

	
Total Revenue
	
	
18 880

	
Materials and energy
	
11 069

	
Production costs
	
	

	
Cost of sales
	
	
11 069

	
Gross profit
	
	
7 811

	
 Gross margin
	
	
41,4%

	
Freight and commisions
	

	
Sales and marketing costs
	
5 500

	
Regional admin
	
	

	
Research and development
	

	
Accrued/(prepaid) expenses
	

	
Divisional overheads
	

	
Corporate overheads
	

	
Loss on receivable (N)
	

	
Other (income)/expense, net
	

	
Amortization (N)
	
	

	
Total operating expense
	
5 500

	
 In % of Total revenue
	
29,1%

	
Operating Income
	
	
2 311

	
 Operating margin
	
12,2%

Comments:

A full break- down of sales and marketing costs on vitamin/non vitamin products is not available.

Advertising etc related to vitamin are estimated.SUPPLY AND PACKAGING AGREEMENT

SUPPLY AND PACKAGING AGREEMENT

 

This Supply and Packaging Agreement (the "Agreement") is made and entered into this  30 day of January, 2003, (the "Effective Date") by and between Alpharma AS, a company organised and existing under the laws of Norway, with organization no. 971 135 123 (herein referred to as "Supplier") and Nopal AS, a company organised and existing under the laws of Norway, with organization no. 917 811 873 (herein referred to as "Buyer")

 

 

WHEREAS the terms used in the Preamble shall have the meanings defined in Article 1;

WHEREAS Supplier is willing to supply the Products to Buyer under the terms and conditions set forth hereinafter,

NOW THEREFORE, in consideration of the mutual promises and covenants set forth herein and for good and valuable consideration, the adequacy and sufficiency of which is hereby acknowledged, the parties hereby agree as follows:

 

1.   Definitions

1.1   The term "Force Majeure" shall mean any event beyond the control of the party affected that prevents or delays the performance of its obligations hereunder. 

1.2   The term "Manufacture" shall mean all the activities relating to production of the Manufactured Products, from purchasing Raw Materials to packaging and shipping Manufactured Products including, but not limited to, purchasing Raw Materials, production, quality control and assurance, filling, labelling, packaging and finishing, release, holding and storage and the tests and analyses conducted in connection therewith.

1.3   The term "Manufactured Products" shall mean the Products listed on Appendix 1 as described in the relevant Specifications, supplied in a form ready for end consumer use.

1.4   The term "Package" means the act of placing Products in Packaging Materials.

1.5   The term "Packaged Products" means the Products listed on Appendix 2.

1.6   The term "Packaging Materials" means the materials used to package the products after all artwork, copy and other written material has been placed thereon by Buyer and also includes all labels, leaflets and other product inserts in the form in which Buyer desires for inclusion in the Products.

1.7   The term "Products" means Manufactured Products and Packaged Products.

1.8   The term "Specifications" shall mean the technical requirements with respect to the Manufactured Products as set forth on Appendix 3.

1.9   The term "Raw Materials" shall mean the Active Ingredient, all other raw materials, intermediate products and packaging materials required to Manufacture the Manufactured Products.

1.10  The term "Supplier Error" shall mean the failure to perform, the negligent performance or willful misconduct in the performance, by the Supplier, its Affiliates or their respective officers, agents or employees of any obligation imposed upon or assigned to Supplier under this Agreement.

1.11  The term "Territory" shall mean Norway.

2.   Purchase and Delivery

2.1   During the term of this Agreement and subject to the provisions herein, Buyer shall purchase from Supplier and Supplier agrees to Manufacture, Package and supply to Buyer, the Manufactured  Products for sale in the Territory.

2.2   Buyer, at its risk, cost and expense, shall timely provide to Seller all Raw Materials necessary to Manufacture and Package the Manufactured Products hereunder.  All required Raw Materials shall be at Suppliers manufacturing facility at least 12 weeks prior to the date upon which Manufactured Products utilizing such Raw Materials are to be delivered to Buyer.  Supplier shall supply the Packaging Materials for the Manufactured Products at its cost and expense; provided that it shall not be responsible for late delivery of Packaging Material  ordered in a timely fashion.

2.3   During the term of this Agreement, and subject to the provisions herein, Supplier shall Package the Packaged Products and supply the Packaged Products to Buyer for sale in the Territory.   

2.4   Buyer, at is risk, cost and expense, shall timely provide to Seller the Packaged Products .  All required Packaged Products shall be at Suppliers manufacturing facility at least 6 weeks prior to the date upon which the Packaged Products are to be delivered to Buyer will all Packaging completed.  Supplier shall supply the Packaging Materials for the Packaged Products at its cost and expense; provided that it shall not be responsible for the late delivery of Packaging Material ordered in a timely fashion.

2.5   Buyer shall be responsible for providing Supplier with the design and content of the Packaging Materials including without limitation assuring itself that the Packaging Materials meet all requirements of law and contain all warning, risks and instructions necessary or reasonable to give in connection with the use of the Manufactured or Packaged Products.

2.6   The prices to be paid by Buyer to Supplier for the Products as well as terms of payment are stated in Appendix 4. Said prices take into consideration the fact that Buyer is supplying all Raw Materials for Manufactured Products and all Packaged Products and that Supplier is supplying all Packaging Materials for Manufactured and Packaged Products at its cost.  If, pursuant to the agreement of the parties, Supplier purchases Raw Materials from time to time, the cost of those Raw Materials shall be added to the prices set forth in Appendix 4.  Cost of transport packaging is included in the prices. Payment shall be effected in NOK by bank transfer.

2.7   No less than 30 days = Manufactured Products, 10 days = Packaged Products prior to the first day of each calendar quarter during the term of the Agreement Buyer shall submit firm purchase orders for the full period of the then succeeding calendar quarter to Supplier in writing. The initial purchase order shall cover the first quarter of 2003 and shall be submitted by Buyer concurrently with the execution of this Agreement.  All purchase orders shall be for multiples of the batch sizes as set forth in Appendixes 1 or 2 and shall contain such other details as reasonably requested by Supplier. 

2.8   No firm purchase order shall be binding on Supplier until accepted in writing with confirmation of the date of shipment. 

2.9   The terms and conditions of this Agreement shall prevail if the terms and conditions stated in Buyer's order or in Supplier's order confirmations or in any other communication of the parties relating to the order are inconsistent with these terms and conditions.

Buyer may request Supplier to increase orders already placed or to change date of shipment. Upon receipt of such request Supplier shall inform Buyer within five (5) working days whether it can accept such additional orders, wholly or in part. In case of partial acceptance, Supplier shall specify quantities and date of shipment.

2.10  Terms of delivery are stated in Appendix 5 

It is of essence to this Agreement that Supplier delivers the Products at the date of shipment stated in the order confirmation. If Supplier is unable, for any reason other than Force Majeure, to fulfil a binding order in accordance with its terms, then Buyer may order Products from a third party (and Supplier shall cooperate by providing all necessary technical information) and Supplier shall be liable to Buyer for all direct losses it has suffered as a result of the breach of contract but shall not be liable for any indirect or consequential damages.  

2.11  Title to and risk of loss of all Products shipped hereunder shall remain with the Supplier until delivered to Buyer in accordance herewith, at which time Buyer shall assume title to and risk of loss in respect of such Products and Product lot samples.

2.12  Supplier may refuse or delay delivery any firm order of Buyer without penalty to the extent that it is unable to fulfil such order because of a shortage in manufacturing or packaging capacity in which event Supplier may allocate available manufacturing capacity in any reasonable manner.

3.   Manufacture, Quality

3.1   Supplier warrants that the Manufactured Products supplied shall be Manufactured in accordance with the provisions of the Specifications; provided that Supplier shall not be responsible if the Raw Materials do not meet Specifications.  Supplier's sole warranty with respect to Packaged Products shall be that they are packaging in a good and workmanlike manner.  All other warranties or representation with respect to the Products, whether express or implied, is hereby excluded.

 3.2   Supplier warrants that it has all the necessary licences and permits from the authorities to Manufacture the Products.

3.3   All complaints with respect to the packaging of Packaged Products and any complaint regarding obvious qualitative faults and/or quantitative failures to meet the provisions of the Specifications with respect to Manufactured Products shall be made in writing by Buyer to Supplier within thirty (30) days after receipt and Buyer shall simultaneously send samples of faulty Products to Supplier. If Buyer fails to notify Supplier within such period, Buyer shall be deemed to have accepted the Product.

3.4   Buyer shall notify Supplier without undue delay of Buyer becoming aware of any defects in the Manufactured Products caused by a failure of Supplier to follow the Specifications which may not or would not have been obvious at delivery by visual inspection of such Products made with reasonable care.

3.5   In cases of justified and properly notified objections under the terms of section 3.4 above, Supplier shall replace the defective Manufactured Products as quickly as possible free of charge, and quantitative deficiencies shall be made up free of charge and, to the extent payment for such defective Manufactured Products had not been made, payment shall be postponed until such replacement quantities are received and accepted by Buyer or at Buyer's choice, Supplier shall refund any amounts paid in respect of such quantities. 

3.6   It is hereby agreed that in the event that Supplier does not acknowledge the failure of such Manufactured Products to meet the Specifications after Buyer has alleged such defect, the parties shall endeavour to settle such disagreement amicably and constructively between themselves. In the event that they fail to agree within 4 (four) weeks after receipt of the notice of defects, the parties agree to nominate an independent, reputable laboratory, acceptable to both parties, which shall examine representative samples taken from such consignment, using the methods of analysis reasonable in the circumstances. The result shall be binding on both parties. The charges for such examination shall be borne by the party found to be at fault.

3.7   Supplier's responsibility for defective Manufactured Products supplied to Buyer hereunder is limited to the replacement only and shall not cover any defect or failure to meet the Specifications caused by or related to the Raw Materials. Supplier's responsibility for Packaged Products shall be limited to replacement of the Packaging Materials.  This, however, does not limit Supplier's responsibility pursuant to Article 4 of this Agreement.

3.8   Buyer shall be solely responsible for all contacts and communications with any Governmental or Regulatory Authority with respect to all matters relating to the Products, except with respect to matters relating to obtaining all requisite approvals from the relevant Governmental or Regulatory Authority to establish the facility as an approved site to Manufacture the Product hereunder which shall be the responsibility of Supplier.

3.9   If any withdrawal or recall of Products as required by applicable law results from Supplier Error, the Supplier shall reimburse Buyer for, but only for,  (i) the reasonable costs incurred by Buyer to effect the withdrawal or recall, (ii) any purchase price and other amounts paid to the Supplier by Buyer in respect of such recalled or withdrawn Products. 

4.   Indemnification and Insurance

4.1   Supplier shall indemnify Buyer and its agents, directors, officers, and employees and representatives and hold them harmless from any personal injury claims, demands, liabilities, suits or expenses of any kind brought by any Governmental or Regulatory authority or third party against Buyer to the extent arising out of or from (i) any breach of its representations, warranties or obligations under this Agreement, (ii) the possession, use or consumption by any person of any Product supplied by the Supplier under this Agreement that does not comply with the Specifications unless such non-compliance relates to or is caused by the Raw Materials; or (iii) any other negligent act or omission on the part of the Supplier, its Affiliates or their respective employees or agents.

4.2   Buyer shall indemnify Supplier and its agents, directors, officers, and employees and representatives and hold them harmless from any claims, demands, liabilities, suits, or expenses of any kind brought by any Governmental or Regulatory authority or third party against Buyer to the extent arising out of or resulting from (i) any breach of its representations, warranties or obligations under this Agreement; (ii) the possession, use or consumption by any person of any Product supplied by Supplier which fully complies with the Specifications, (iii) the provision of Raw Materials or Packaging Materials which do not meet the Specifications and (iv) any other negligent act or omission on the part of Buyer or its Affiliates or their respective employees or agent.

4.3   Supplier represents and warrants that it has at least EURO 2 (two) million product liability insurance coverage covering its liabilities for the Products set forth in Section 4.1. This insurance coverage shall be upheld throughout the term of this Agreement, and if such insurance is provided on a "claims-made" basis, for a period of not less than five years thereafter. The insurance policy shall include Buyer as an additional insured and a "Certificate of Insurance" shall be submitted to Buyer as soon as possible after the execution of this Agreement and at each subsequent renewal of the insurance policy.

4.4   Section 4 shall survive termination of this Agreement.

5.  Relationship Between Parties

The relationship of the parties under this Agreement is that of independent contractors. 

 

6.  Effective Date and Duration

6.1   This Agreement shall be effective from the date hereof and shall expire on June 30, 2003 subject to Buyer's option to extent this Agreement until December 31, 2003 by giving notice of the exercise of such option on or before June 1, 2003. 

6.2   The parties agree that this Agreement may be terminated by written notice to the other party at any time whenever any of the following events shall occur:

a)If the other party breaches any of the terms of this Agreement and fails to remedy such breach within sixty (60) days after notice requiring it to do so, the non-breaching party shall have the right to terminate this Agreement.

b)Either party shall be entitled to terminate this Agreement forthwith in case a proceeding of bankruptcy or composition shall be instituted against the other party.

	As provided for elsewhere in this Agreement or by applicable law.

 

6.3   All such notices shall be personally delivered, mailed by registered mail, sent by telefax confirmed by telephone conversation with the recipient, or sent by DHL, or similar courier requiring signature on receipt, addressed as follows:

 

	
Supplier:   
	
Buyer:

	 	 
	
Alpharma AS

Harbitzalleen 3, P.O. Box 158 Skoyen

N-0212 Oslo
	
Nopal AS

Billingstadsletta 25, P.O. Box 134

N-1376 Billingsad

	 	 
	
Attention: Thor Kristiansen 
	
Attention: Tor Harung

	 	 
	
Telephone: 2252 9200

Telefax:  2252 9662
	
Telephone:  6677 6100

Telefax:   6677 6160

7.  Assignment 

This Agreement shall not be assigned to third parties without the prior written consent of the other party. Either party may at any time assign this Agreement to an Affiliate without the other party's prior consent.

8.   Force Majeure

Neither party shall be considered in default in the performance of its obligations hereunder, or be liable in damages or otherwise because of Force Majeure. 

9.   Severability

If any provision of this Agreement is found by any court or administrative body of competent

jurisdiction to be invalid or unenforceable, the invalidity or unenforceability of such provision

shall not affect the other provisions of this Agreement, and all provisions not affected by such

invalidity or unenforceability shall remain in full force and effect.  The parties agree to attempt

to substitute for any invalid or unenforceable provision a valid or enforceable provision which

achieves to the greatest extent possible the economic objectives of the invalid or unenforceable

provision.

10.   Governing Law and Dispute Resolution
This Agreement shall be governed by and interpreted under the laws of Norway. The United

Nations Convention on Contracts for the International Sale of Goods shall have no

application to this Agreement and is hereby excluded.

 

11.   Entire Agreement, Modifications and Interpretation
a)  This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereto, and supersedes all prior agreements between the parties, whether written or oral, relating to the same subject matter.

b)  No modifications, amendments or supplements to this Agreement shall be effective for any purpose unless in writing signed by each party.  Approvals or consents hereunder by a party shall also be in writing.  

*************

IN WITNESS WHEREOF the parties have caused this Agreement to be executed by their duly authorised representatives on the date first written above.

 

	
/s/ Thor Kristiansen
	
/s/ Tor Harung

	
Name:  Thor Kristiansen

Title:     Gen. Mngr.
	
Name:  Tor Harung

Title:     President

	 	 

 

 

Appendix 1

MANUFACTURED PRODUCTS

VITAPLEX TAB 8X80

VITAPLEX TAB 1000

 

Appendix 2

 

PACKAGED PRODUCTS

VITAPAN TRANPERLER 1000 ENP

VITAPAN TRANPERLER 150 APOTEK

VITAPLEX ABCDE + MIN 8X80

VITAPLEX BARNEVITAMIN 8X80

VITAPLEX B-VITAMIN 8X80

VITAPLEX C-VITAMIN 8X80

VITAPLEX HVITLØK 8X80

VITAPLEX KOSTTILSKUDD ENP

VITAPLEX MAGNESIUM 100 APOTEK

NORVITON 90 TAB 10 PAK

Appendix 3

 

SPECIFICATIONS

 

Appendix 4

PRICE LIST FOR MANUFACTURING AND PACKAGING PRODUCTS

	
	
Manufacturing
	
Bulk
	
Packaging

	
	
NOK/unit
	
NOK/unit
	
NOK/unit

	
VITAMINERAL TAB 100 NO        
	
	
14,02
	

	
VITAMINERAL TAB 250 NO        
	
	
28,16
	

	
VITAPAN TRANPERLER 1000ENP    
	
	
0,00
	

	
VITAPAN TRANPERLER 150 APOTEK 
	
	
0,00
	

	
VITAPLEX ABCDE+8 MIN 8X80ENP  
	
	
55,10
	
40,00

	
VITAPLEX BARNEVITAMIN 8X80ENP 
	
	
0,00
	

	
VITAPLEX B-VITAMIN 8X80ENP    
	
	
36,90
	
50,00

	
VITAPLEX C-VITAMIN 8X80ENP    
	
	
48,80
	
40,00

	
VITAPLEX FRISKHALS 10X20ENP   
	
	
61,40
	

	
VITAPLEX HVITLØK 8X80ENP      
	
	
68,40
	
30,00

	
VITAPLEX KOSTTILSKUDD ENP     
	
	
110,50
	

	
VITAPLEX MAGNESIUM 100 APOTEK 
	
	
0,00
	

	
VITAPLEX TAB 1000             
	
102,51
	
50,00
	
52,50

	
VITAPLEX TAB 8X80ENP          
	
85,76
	
50,00
	
40,00

	
VITAPLEX VITAMINERAL 100 NO   
	
	
14,02
	

	
NORVITON 90 TAB 10 PAK
	
	
16,10
	
6,00

Payment terms net 45 days.

 

Appendix 5

TERMS OF DELIVERY

Manufactured and packaged products are delivered to buyers warehouse at Elverum, CPT ( as such term is defined in the current edition of "Incoterms") net 45 days.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00048-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00048-of-00352.parquet"}]]